UBS ETF (CH) MSCI Switzerland (CHF) A-dis is an exchange-traded fund that seeks to replicate the price and yield performance of the MSCI Switzerland index through physical full replication. Launched on 31 October 2013 and domiciled in Switzerland, it invests in large and mid-cap stocks from the Swiss market, holding approximately 42 constituents with top holdings including Nestlé SA, Novartis AG, and Roche Holding AG, which together account for over 70% of the portfolio. The fund emphasizes sectors such as Health Care (around 33-36%), Financials (18-21%), and Consumer Staples (15-17%), providing diversified exposure primarily to Swiss companies (over 94%) available to global investors. With a total expense ratio of 0.21% p.a., it distributes dividends annually, typically in September, and maintains a fund size of about EUR 811 million (or CHF 566 million as of late 2024). This ETF plays a key role in offering cost-efficient, transparent access to Switzerland's leading equity market performance, unhedged in Swiss Francs, for investors seeking passive exposure to this stable economy.